✦ LIBER ✦
Safety, Tolerability, Pharmacokinetics and Antitumor Activity of Ganitumab, an Investigational Fully Human Monoclonal Antibody to Insulin-like Growth Factor Type 1 Receptor, Combined with Gemcitabine as First-line Therapy in Patients with Metastatic Pancreatic Cancer: A Phase 1b Study
✍ Scribed by Okusaka, T.; Ikeda, M.; Fukutomi, A.; Kobayashi, Y.; Shibayama, K.; Takubo, T.; Gansert, J.
- Book ID
- 126718427
- Publisher
- Oxford University Press
- Year
- 2014
- Tongue
- English
- Weight
- 157 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0368-2811
No coin nor oath required. For personal study only.